secwatch / observer
8-K filed June 16, 2023, 7:59 PM ET ticker BBLG CIK 0001419554
other material confidence high sentiment negative materiality 0.65

Bone Biologics prices $5M underwritten public offering of 2.5M shares at $1.97/share

Bone Biologics Corp

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Bone Biologics Corp entered into Underwriting Agreement with EF Hutton, division of Benchmark Investments, LLC valued at 2,538,071 shares of common stock at $1.97 per share; underwriter option for up to 380,710 additional (effective 2023-06-14).

Action
entry
Agreement
underwriting
Counterparty
EF Hutton, division of Benchmark Investments, LLC
Value
2,538,071 shares of common stock at $1.97 per share; underwriter option for up to 380,710 additional
Effective
2023-06-14
Exact text from the filing
On June 14, 2023, Bone Biologics Corporation (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with EF Hutton, division of Benchmark Investments, LLC (“EF Hutton”) acting as representatives of the several underwriters (the “Underwriters”) in connection with a public offering (the “Offering”) of the Company’s securities.
View on SEC.gov

Browse all material agreements →

Bone Biologics Corp filing history →

Source: SEC EDGAR
accession 0001493152-23-021605
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.